Concepedia

Julie Chesneau

JC

11

Publications

454

Citations

11

H-Index

2011

Active since

Affiliations

Inserm(Current)

Nantes Université

La Ligue Contre le Cancer

Centre National de la Recherche Scientifique

Institut de Biologie Moléculaire et Cellulaire

Julie Chesneau is an author at Inserm specializing in medicine, tumor biology, and osteoporosis.

Top concepts

Publications per year

2011–2016

11

Publications

11

Overexpression of Smad7 Blocks Primary Tumor Growth and Lung Metastasis Development in Osteosarcoma

Audrey Lamora, Julie Talbot, Gwenola Bougras et al. · Clinical Cancer Research · 2014 · 112 citations

NVP-BEZ235, a dual PI3K/mTOR inhibitor, inhibits osteosarcoma cell proliferation and tumor development in vivo with an improved survival rate

Bérengère Gobin, Séverine Battaglia, Rachel Lanel et al. · Cancer Letters · 2013 · 81 citations · Full text

, , +10

Skeletal consequences of RANKL-blocking antibody (IK22-5) injections during growth: Mouse strain disparities and synergic effect with zoledronic acid

Frédéric Lézot, Julie Chesneau, Benjamin Navet et al. · Bone · 2014 · 39 citations

, , +11

Formulated siRNAs targeting <i>Rankl</i> prevent osteolysis and enhance chemotherapeutic response in osteosarcoma models

Julie Rousseau, Virginie Escriou, François Lamoureux et al. · Journal of Bone and Mineral Research · 2011 · 38 citations · Full text

Impact of oncopediatric dosing regimen of zoledronic acid on bone growth: Preclinical studies and case report of an osteosarcoma pediatric patient

Séverine Battaglia, Sophie Dumoucel, Julie Chesneau et al. · Journal of Bone and Mineral Research · 2011 · 38 citations

Rows per page

1–5 of 11